Business
Appalachian Mountain Brewery, Inc. CEO Provides Update to Shareholders and Creates a Strategic Advisory Board
Appalachian Mountain Brewery, Inc. CEO Provides Update to Shareholders and Creates a Strategic Advisory Board.
About this update from Optimus Healthcare Services, Inc.
[{"type":"text","content":"NORTH MIAMI, FL / ACCESSWIRE / October 10, 2018/ Appalachian Mountain Brewery, Inc. (OTC PINK: HOPS) ("AMB") is pleased to announce that both Dr. Richard Drucker and Michael Pruitt, existing statutory board members of AMB, Inc. and leading industry professionals in the realms of medicine and entrepreneurship have helped to create and subsequently join the Strategic Advisory Board. The "SAB" sole purpose is to provide the CEO of the Company with the knowledge, understanding and strategic forward thinking along with varying perspectives of the current and future Advisory Board Members. The current and future members of the "SAB" will represent a well-diversified group in arenas such as Operations, Regulatory Compliance, Applied Science, Medical Research, Investor Relations, Legal as well as M&A work. The Advisory Board was created to supplement the AMB statutory board's knowledge in areas to include but not limited to the business of HEMP cultivation, processing, extraction as well as end use CBD products that have put CBD and HEMP in the headlines. "In representing the long-term interests of our shareholders, we have created the "SAB" to ensure that AMB is engaging big picture kind of thinking by looking to the thought leaders and influencers in various respective industry. CBD and HEMP continue to capture our nations headlines for both medicinal and recreational purposes and it is clear that the opportunity to grow a CBD and HEMP brand is well within our grasp with the right players involved. We also believe that there is real tangible evidence that CBD extracted from HEMP is making a real difference in the lives of those affected by PTSD, TBI, Chronic Pain, Anxiety, Seizures, Stress as well as a viable substitute for the abuse of prescription drugs that have created an Opioid epidemic that is sweeping the country. We believe it is our duty to the long-term interest of our shareholders to stay abreast of these kinds of trends and make sure we're capitalizing on the opportunities when we see how it can clearly enhance long-term shareholder value while changing the world with the businesses and products we produce," stated Sean Spiegelman, CEO. The "SAB" will not provide a consensus or vote on a course of action for the Company. The members have agreed to interact wit...